Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10873570rdf:typepubmed:Citationlld:pubmed
pubmed-article:10873570lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C0029463lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C1383501lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C0012328lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C0037906lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C0243127lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C1515877lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:10873570lifeskim:mentionsumls-concept:C0443331lld:lifeskim
pubmed-article:10873570pubmed:issue1lld:pubmed
pubmed-article:10873570pubmed:dateCreated2000-7-27lld:pubmed
pubmed-article:10873570pubmed:abstractText1,25-Dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] initiates the hydrolysis of sphingomyelin in ROS 17/2.8 osteosarcoma cells with the resultant generation of cell-associated ceramide. Increases in ceramide levels were detectable at 15 min and maximal one hour after exposure of cells to 1,25(OH)(2)D(3). Neither 1,25(OH)(2)D(3) nor exogenous ceramide elicited a change in cytosolic free Ca(2+) ([Ca(2+)](i)). Transient elevations in [Ca(2+)](i) were observed when cells were exposed to exogenous sphingosine, but there was no detectable conversion of ceramide to sphingosine in 1, 25(OH)(2)D(3)-treated cells. Ceramide also did not stimulate Ca(2+) uptake across ROS 17/2.8 cell plasma membranes. Collectively, these results suggest that 1,25(OH)(2)D(3) activates sphingomyelin turnover in ROS 17/2.8 osteosarcoma cells but that the sphingolipid metabolite ceramide is not responsible for 1,25(OH)(2)D(3)-induced activation of plasma membrane Ca(2+) channels.lld:pubmed
pubmed-article:10873570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:languageenglld:pubmed
pubmed-article:10873570pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:citationSubsetIMlld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10873570pubmed:statusMEDLINElld:pubmed
pubmed-article:10873570pubmed:monthJunlld:pubmed
pubmed-article:10873570pubmed:issn0006-291Xlld:pubmed
pubmed-article:10873570pubmed:authorpubmed-author:VogelJ JJJlld:pubmed
pubmed-article:10873570pubmed:authorpubmed-author:LidMMlld:pubmed
pubmed-article:10873570pubmed:authorpubmed-author:KarinN JNJlld:pubmed
pubmed-article:10873570pubmed:authorpubmed-author:XuYYlld:pubmed
pubmed-article:10873570pubmed:authorpubmed-author:Farach-Carson...lld:pubmed
pubmed-article:10873570pubmed:copyrightInfoCopyright 2000 Academic Press.lld:pubmed
pubmed-article:10873570pubmed:issnTypePrintlld:pubmed
pubmed-article:10873570pubmed:day24lld:pubmed
pubmed-article:10873570pubmed:volume273lld:pubmed
pubmed-article:10873570pubmed:ownerNLMlld:pubmed
pubmed-article:10873570pubmed:authorsCompleteYlld:pubmed
pubmed-article:10873570pubmed:pagination95-100lld:pubmed
pubmed-article:10873570pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:meshHeadingpubmed-meshheading:10873570...lld:pubmed
pubmed-article:10873570pubmed:year2000lld:pubmed
pubmed-article:10873570pubmed:articleTitle1,25 dihydroxyvitamin D(3) activates sphingomyelin turnover in ROS17/2.8 osteosarcoma cells without sphingolipid-induced changes in cytosolic Ca(2+).lld:pubmed
pubmed-article:10873570pubmed:affiliationDepartment of Biological Sciences, University of Delaware, Newark, Delaware, USA.lld:pubmed
pubmed-article:10873570pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10873570pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed